4/A
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-19-048857
Chairman and CEO bought 19,500 shares at an average $3.38 ($65,975)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2019-08-19 | Purchase | +6,500 | $3.39 | $22,035 | 10,170,293 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-20 | Purchase | +6,500 | $3.39 | $22,035 | 10,176,793 | D |
| Niihara Yutaka Chairman and CEO | 2019-08-21 | Purchase | +6,500 | $3.37 | $21,905 | 10,183,293 | D |
| Open-market purchases · 19,500 sh · avg $3.38 · $65,975 | |||||||
Loading xslF345X03/doc4a.xml…